How big is the Sterile Injectable Contract Manufacturing Market?

The Sterile Injectable Contract Manufacturing Market size is expected to reach USD 16.17 billion in 2025 and grow at a CAGR of 12% to reach USD 28.50 billion by 2030. Read More

What is the current Sterile Injectable Contract Manufacturing Market size?

In 2025, the Sterile Injectable Contract Manufacturing Market size is expected to reach USD 16.17 billion. Read More

Who are the key players in Sterile Injectable Contract Manufacturing Market?

Baxter, Catalent, Inc, Vetter Pharma, Recipharm AB and Aenova Group are the major companies operating in the Sterile Injectable Contract Manufacturing Market. Read More

Which is the fastest growing region in Sterile Injectable Contract Manufacturing Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030). Read More

Which region has the biggest share in Sterile Injectable Contract Manufacturing Market?

In 2025, the North America accounts for the largest market share in Sterile Injectable Contract Manufacturing Market. Read More

What years does this Sterile Injectable Contract Manufacturing Market cover, and what was the market size in 2024?

In 2024, the Sterile Injectable Contract Manufacturing Market size was estimated at USD 14.23 billion. The report covers the Sterile Injectable Contract Manufacturing Market historical market size for years: 2021, 2022, 2023 and 2024. The report also forecasts the Sterile Injectable Contract Manufacturing Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030. Read More

Sterile Injectable Contract Manufacturing Companies

This report lists the top Sterile Injectable Contract Manufacturing companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Sterile Injectable Contract Manufacturing industry.